Morgan Cheatham is a vice president with Bessemer Venture Partners where he leads healthcare and life sciences investments across the value chain spanning software, therapeutics, services, and diagnostics to improve patient care from bench to bedside. Morgan is completing medical training at The Warren Alpert Medical School of Brown University with research focuses in artificial intelligence and genomics. His research collaborations include the Stanford Institute for Human-Centered AI, Harvard Department of Biomedical Informatics, and the National Human Genome Research Institute. He is a Board Director at the Coalition for Health AI and a member of the New England Journal of Medicine Artificial Intelligence Editorial Team.